Updated on 2024/10/07
日本腎臓学会 学術委員会SRチーム
2018.4
Committee type：Academic society
腎障害患者におけるヨード造影剤使用に関するガイドライン2018
PKDガイドライン2020
CKDガイドライン2023
PKDガイドライン2026
日本女性腎臓病医の会（JSWN）研究活動奨励賞
2023.6 日本女性腎臓病医の会 微小変化型ネフローゼに対するリツキシマブ治療の作用機構の全容解明を目指して－ヒト末梢血白血球の網羅的解析を通して
Prognosis of microscopic polyangiitis is well predictable in the first 2 weeks of treatment Reviewed
Owaki A; Tanaka A; Kazuhiro Furuhashi; Watanabe Y; Koshi-Ito E; Imaizumi T; Maruyama S
Clinical and experimental nephrology Vol. 28 ( 7 ) page： 701 - 706 2024.7
Associations of time-dependent changes in phosphorus levels with cardiovascular diseases in patients undergoing hemodialysis: results from the Japan Dialysis Active Vitamin D (J-DAVID) randomized clinical trial. Reviewed
Koshi-Ito E, Inaguma D, Ishii H, Yuzawa Y, Kabata D, Shintani A, Inaba M, Emoto M, Mori K, Morioka T, Nakatani S, Shoji T
Clinical kidney journal Vol. 15 ( 12 ) page： 2281 - 2291 2022.12
Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis. Reviewed
Kitai H, Kato N, Ogami K, Komatsu S, Watanabe Y, Yoshino S, Koshi E, Tsubota S, Funahashi Y, Maeda T, Furuhashi K, Ishimoto T, Kosugi T, Maruyama S, Kadomatsu K, Suzuki HI
BMC biology Vol. 20 ( 1 ) page： 248 2022.11
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020. Reviewed
Nishio S, Tsuchiya K, Nakatani S, Muto S, Mochizuki T, Kawano H, Hanaoka K, Hidaka S, Ichikawa D, Ishikawa E, Uchiyama K, Koshi-Ito E, Hayashi H, Makabe S, Ogata S, Mitobe M, Sekine A, Suwabe T, Kataoka H, Kai H, Kaneko Y, Kurashige M, Seta K, Shimazu K, Hama T, Miura K, Nakanishi K, Horie S, Furuichi K, Okada H, Narita I, Committee of Clinical Practical Guideline for Polycystic Kidney Disease 2020
Clinical and experimental nephrology Vol. 25 ( 12 ) page： 1292 - 1302 2021.12
Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis. Reviewed
Koshi-Ito E, Inaguma D, Koide S, Takahashi K, Hayashi H, Tsuboi N, Hasegawa M, Maruyama S, Yuzawa Y
Renal failure Vol. 43 ( 1 ) page： 1528 - 1538 2021.12
Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019. Reviewed
Koshi E, Saito S, Okazaki M, Toyama Y, Ishimoto T, Kosugi T, Hiraiwa H, Jingushi N, Yamamoto T, Ozaki M, Goto Y, Numaguchi A, Miyagawa Y, Kato I, Tetsuka N, Yagi T, Maruyama S
CEN case reports Vol. 10 ( 1 ) page： 126 - 131 2021.2
Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study. Reviewed
Yoshida H, Inaguma D, Koshi-Ito E, Ogata S, Kitagawa A, Takahashi K, Koide S, Hayashi H, Hasegawa M, Yuzawa Y, Tsuboi N
Renal failure Vol. 42 ( 1 ) page： 646 - 655 2020.11
Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Reviewed
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Joint Working Group
Clinical and experimental nephrology Vol. 24 ( 1 ) page： 1 - 44 2020.1
Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Reviewed
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Joint Working Group
Japanese journal of radiology Vol. 38 ( 1 ) page： 3 - 46 2020.1
Effect of Low-Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy. Reviewed
Koshi-Ito E, Koike K, Tanaka A, Watanabe Y, Kamegai N, Shimogushi H, Shinjo H, Otsuka Y, Inaguma D, Takeda A
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy Vol. 23 ( 6 ) page： 575 - 583 2019.12
Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018. Reviewed
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology, Japan Radiological Society, Japanese Circulation Society Joint Working Group
Circulation journal : official journal of the Japanese Circulation Society Vol. 83 ( 12 ) page： 2572 - 2607 2019.11
Relationship Between Patterns in Antihypertensive Drugs Medication and Mortality in Incident Dialysis Patients: A Multicenter Prospective Cohort Study. Reviewed
Fujii M, Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Tsuboi N, Hasegawa M, Yuzawa Y
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy Vol. 23 ( 4 ) page： 353 - 361 2019.8
Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients. Reviewed
Inaguma D, Morii D, Kabata D, Yoshida H, Tanaka A, Koshi-Ito E, Takahashi K, Hayashi H, Koide S, Tsuboi N, Hasegawa M, Shintani A, Yuzawa Y
PloS one Vol. 14 ( 8 ) page： e0221352 2019
Relationship between History of Ischemic Stroke and All-Cause Mortality in Incident Dialysis Patients. Reviewed
Kojima M, Inaguma D, Koide S, Koshi-Ito E, Takahashi K, Hayashi H, Tsuboi N, Hasegawa M, Yuzawa Y
Nephron Vol. 143 ( 1 ) page： 43 - 53 2019
Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method. Reviewed
Ito E, Inaguma D, Koide S, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y
Clinical and experimental nephrology Vol. 22 ( 6 ) page： 1309 - 1314 2018.12
Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan. Reviewed
Inaguma D, Ito E, Takahashi K, Hayashi H, Koide S, Hasegawa M, Yuzawa Y, AICOPP Group
Clinical and experimental nephrology Vol. 22 ( 6 ) page： 1360 - 1370 2018.12
Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study. Reviewed
Owaki A, Inaguma D, Aoyama I, Inaba S, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y, AICOPP group
Renal failure Vol. 40 ( 1 ) page： 475 - 482 2018.11
Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis. Reviewed
Inaguma D, Sasakawa Y, Suzuki N, Ito E, Takahashi K, Hayashi H, Koide S, Hasegawa M, Yuzawa Y, Tokai Aortic Stenosis in Dialysis Patients Cohort Study Group
BMC nephrology Vol. 19 ( 1 ) page： 80 2018.4
Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study. Reviewed
Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y, AICOPP group
Clinical and experimental nephrology Vol. 22 ( 2 ) page： 353 - 364 2018.4
Combination Therapy with Renin-Angiotensin System Blockers and Vitamin D Receptor Activators for Predialysis Patients Is Associated with the Incidence of Cardiovascular Events after Dialysis Initiation: A Multicenter Nonrandomized Prospective Cohort Study. Reviewed
Inaguma D, Ito E, Koide S, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y
Cardiorenal medicine Vol. 8 ( 1 ) page： 71 - 81 2017.12
Elucidation of the Immune Regulatory Mechanisms Involved in the Treatment and Responsiveness of IgA Nephropathy Using Multi-Omics Analysis
Grant number：24K23431 2024.9
Authorship：Principal investigator Grant type：Competitive
Grant amount：\2860000 （ Direct Cost: \2200000 、 Indirect Cost：\660000 ）
難治性の希少腎疾患に対する治療最適化に向けた研究開発
Grant number：24ek0109753h0001 2024.4
国立研究開発法人 日本医療研究開発機構 令和6年度「難治性疾患実用化研究事業」
Authorship：Coinvestigator(s) Grant type：Competitive
Grant amount：\97500000 （ Direct Cost: \75000000 、 Indirect Cost：\22500000 ）
